Diarrhea News and Research RSS Feed - Diarrhea News and Research

Diarrhea is loose, watery stools. A person with diarrhea typically passes stool more than three times a day. People with diarrhea may pass more than a quart of stool a day. Acute diarrhea is a common problem that usually lasts 1 or 2 days and goes away on its own without special treatment. Prolonged diarrhea persisting for more than 2 days may be a sign of a more serious problem and poses the risk of dehydration. Chronic diarrhea may be a feature of a chronic disease.

Diarrhea can cause dehydration, which means the body lacks enough fluid to function properly. Dehydration is particularly dangerous in children and older people, and it must be treated promptly to avoid serious health problems.
ART could help reduce opportunistic infections and save lives of HIV-infected children

ART could help reduce opportunistic infections and save lives of HIV-infected children

According to the World Health Organization (WHO), 150,000 children with HIV under 15 years of age died of opportunistic infections in low-to-middle income countries in 2014 alone. [More]
Tourists returning from India import multidrug-resistant superbugs

Tourists returning from India import multidrug-resistant superbugs

Many tourists returning from India were found colonized with multidrug-resistant superbugs. Microbiologists at the Institute for Infectious Diseases of the University of Bern, Switzerland, also isolated a strain possessing a gene which can make these life-threatening bacteria resistant to the last active antibiotic option. [More]
Soligenix announces encouraging preliminary results of heat stable Ebola vaccine

Soligenix announces encouraging preliminary results of heat stable Ebola vaccine

A biopharmaceutical company collaborating with Hawai'i scientists on an Ebola vaccine announced encouraging news about its vaccine today. [More]
Low-FODMAP rye bread may reduce symptoms of IBS

Low-FODMAP rye bread may reduce symptoms of IBS

Patients with irritable bowel syndrome (IBS) are often concerned that certain foods may trigger or worsen their symptoms, which can include abdominal pain, diarrhea, or constipation. In a new study, patients who ate rye bread that was low in so-called "FODMAPs" (fermentable oligo- di- and mono-saccharides and polyols) experienced milder IBS symptoms than patients who ate normal rye bread. [More]
Parental substance use increases health risks among children

Parental substance use increases health risks among children

Children whose parents or caregivers misuse alcohol or use, produce or distribute drugs face an increased risk of medical and behavioral problems. According to a new clinical report by experts at Beth Israel Medical Center and Boston Children's Hospital, pediatricians are in a unique position to assess risk and intervene to protect children. [More]
Fecal transplants may help treat home and hospital-acquired scourge

Fecal transplants may help treat home and hospital-acquired scourge

Fecal transplants are increasingly being used as the treatment of last resort for certain infections in the human gut and have had remarkable success treating the nursing home and hospital-acquired scourge, Clostridium difficile colitis, an infectious diarrhea that often follows antibiotic treatment. [More]
European Commission approves extended indication for Amgen's Kyprolis (carfilzomib) for the treatment of relapsed multiple myeloma patients

European Commission approves extended indication for Amgen's Kyprolis (carfilzomib) for the treatment of relapsed multiple myeloma patients

Amgen has announced that the European Commission (EC) has approved a variation to the marketing authorization for Kyprolis® (carfilzomib) to include use in combination with dexamethasone alone for adult patients with multiple myeloma who have received at least one prior therapy. The extended indication marks the second approval for Kyprolis by the EC in less than a year. [More]
Health care resource use and costs of H.P. Acthar® gel for multiple sclerosis relapse

Health care resource use and costs of H.P. Acthar® gel for multiple sclerosis relapse

Mallinckrodt plc, a leading global specialty biopharmaceutical company, today announced new retrospective health economic data on H.P. Acthar® Gel (repository corticotropin injection; RCI), which may be an option for the management of multiple sclerosis (MS) relapses. [More]
Fecal contamination in water can sicken swimmers

Fecal contamination in water can sicken swimmers

Recreational water illness is the overall term for sickness caused by bacteria or viruses in pools, lakes, rivers and other places people like to swim or play in hot weather. [More]
Regorafenib drug improves survival rates in patients with hepatocellular carcinoma

Regorafenib drug improves survival rates in patients with hepatocellular carcinoma

Oral multikinase inhibitor regorafenib achieves significantly improved survival rates compared to placebo in patients with hepatocellular carcinoma, according to data from the phase III RESORCE trial, presented at the ESMO 18th World Congress of Gastrointestinal Cancer in Barcelona, Spain. [More]
Treatment for IBS proves difficult, survey reveals

Treatment for IBS proves difficult, survey reveals

A new national survey by Health Union of more than 1,000 individuals with Irritable Bowel Syndrome (IBS) reveals that the condition is difficult to diagnose and often even more difficult to treat. [More]
Lab-established diagnosis necessary for treatment of patients with persistent diarrhea

Lab-established diagnosis necessary for treatment of patients with persistent diarrhea

Persistent diarrhea, which is diarrhea that lasts at least 14 days, is an illness typically caused by parasites or bacteria and requires accurate diagnosis in order to determine what treatment to give, according to Herbert L. DuPont, M.D., director of the Center for Infectious Diseases at The University of Texas Health Science Center at Houston School of Public Health. [More]
Health strategies for families when traveling abroad with kids

Health strategies for families when traveling abroad with kids

Before your family heads to Mexico, Asia or beyond this summer, do a little planning to keep everyone healthy during their journey. Dr. Nava Yeganeh, an assistant professor of pediatric infectious diseases and director of the Pediatric International Travel and Adoption Clinic at Mattel Children's Hospital UCLA, explains three important strategies. [More]
Portable biosensor can detect and amplify signal of harmful bacteria

Portable biosensor can detect and amplify signal of harmful bacteria

Washington State University researchers have developed a portable biosensor that makes it easier to detect harmful bacteria. [More]
FDA approves novel stomach-draining device to treat obesity

FDA approves novel stomach-draining device to treat obesity

The U.S. Food and Drug Administration today approved a new obesity treatment device that uses a surgically-placed tube to drain a portion of the stomach contents after every meal. [More]
Genetic blood test can help predict patient’s respone to neuroendocrine cancer therapy

Genetic blood test can help predict patient’s respone to neuroendocrine cancer therapy

Malignant neuroendocrine tumors (NETs) are relatively rare, notoriously difficult to treat, and associated with poor long-term survival. According to research presented at the 2016 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging, an investigative blood test could predict how patients will respond to peptide receptor radionuclide therapy (PRRT) before they commit to a course of treatment. [More]
FDA approves Vaxchora for prevention of cholera

FDA approves Vaxchora for prevention of cholera

The U.S. Food and Drug Administration today approved Vaxchora, a vaccine for the prevention of cholera caused by serogroup O1 in adults 18 through 64 years of age traveling to cholera-affected areas. Vaxchora is the only FDA-approved vaccine for the prevention of cholera. [More]
Utah researchers find way to use power of protease to destroy budding AIDS virus

Utah researchers find way to use power of protease to destroy budding AIDS virus

When new AIDS virus particles bud from an infected cell, an enzyme named protease activates to help the viruses mature and infect more cells. That's why modern AIDS drugs control the disease by inhibiting protease. [More]
PD surgery improves quality of life in patients with malignant pleural mesothelioma

PD surgery improves quality of life in patients with malignant pleural mesothelioma

Although surgery can prolong the lives of patients with an aggressive type of cancer called malignant pleural mesothelioma, many patients avoid the operation for fear it will degrade their quality of life. [More]
Scientists explore effects of physiological fluid shear on dangerous type of Salmonella

Scientists explore effects of physiological fluid shear on dangerous type of Salmonella

Once inside the human body, infectious microbes like Salmonella face a fluid situation. They live in a watery world, surrounded by liquid continually flowing over and abrading their cell surfaces--a property known as fluid shear. [More]
Advertisement